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Background:  A fatty acid (FA) is a carboxilic acid with a long aliphatic chain, which is either 
saturated or unsaturated. Recently, the role of FA and particularly omega 3 and 6 has emerged as 
cardiovascular risk factor in the literature. 
The aim of our study was to establish reference value for these FA and to compare these results 
with data obtained in acute myocardial infarction (AMI) patients.
Materials and methods:
• Fifty four healthy subjects (33±11 yo) (23 men) were selected as reference population.. We 
also evaluated FA in thirty three patients (55±9 yo) (23 men) admitted in the Emergency of our 
Institution for AMI. 
•The fasting whole blood was drawn in vacutainer containing EDTA. Before the analysis, the 
samples were washed and transmethylated. 
•We performed the quantification of different FA by gas chromatography associated with flame 
ionization detector (GC/FID).
Results:For the AMI group, the level of 
omega-6 were significantly higher 
(p<0.01) for C18:2n6 (Figure 1) and 
C18:3n6 (Figure 2). The level of omega-3 
was significantly decreased (p<0.01) in 
comparison with reference value for 
C22:6n3 (Figure 3). The omega-3 index 
(sum of DHA* and EPA**) was significantly 
lower (p<0.01) in AMI group compared 
reference value and the ratio omega-
6/omega-3 was significantly higher 
(p<0.01) in AMI than reference patient. 
Conclusion: We have established reference value for FA and compare them with the FA 
determination in AMI group. It is a new tool we are able to use and to process in our laboratory 
which can help the clinician to highlight patients with the most cardiovascular risks seen the 
protector role of polyunsaturated FA particularly, omega3, and the implication of satured FA in the 
development of atherosclerosis.
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